Raymond James & Associates’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-4,373
| Closed | -$56K | – | 3640 |
|
|
2019
Q4 | $56K | Buy |
4,373
+755
| +21% | +$9.67K | ﹤0.01% | 3477 |
|
|
2019
Q3 | $38K | Buy |
3,618
+510
| +16% | +$5.36K | ﹤0.01% | 3441 |
|
|
2019
Q2 | $53K | Buy |
3,108
+42
| +1% | +$716 | ﹤0.01% | 3442 |
|
|
2019
Q1 | $103K | Buy |
3,066
+115
| +4% | +$3.86K | ﹤0.01% | 3351 |
|
|
2018
Q4 | $86K | Buy |
2,951
+521
| +21% | +$15.2K | ﹤0.01% | 3299 |
|
|
2018
Q3 | $150K | Sell |
2,430
-1,115
| -31% | -$68.8K | ﹤0.01% | 3333 |
|
|
2018
Q2 | $262K | Sell |
3,545
-52
| -1% | -$3.84K | ﹤0.01% | 3091 |
|
|
2018
Q1 | $236K | Sell |
3,597
-650
| -15% | -$42.6K | ﹤0.01% | 3030 |
|
|
2017
Q4 | $357K | Sell |
4,247
-1,206
| -22% | -$101K | ﹤0.01% | 2728 |
|
|
2017
Q3 | $630K | Buy |
5,453
+1,857
| +52% | +$215K | ﹤0.01% | 2346 |
|
|
2017
Q2 | $420K | Buy |
+3,596
| New | +$420K | ﹤0.01% | 2516 |
|